Graves Hyperthyroidism Remission Seen With Adjuvant, Single-Dose Rituximab
Graves hyperthyroidism has a remission rate of 20%-30% with standard antithyroid drug treatment, but long-term use can be problematic. Researchers explored whether adjuvant rituximab would aid remission rates.